Target intelligence / Profile preview

Nanog homeobox pseudogene 11 (NANOGP11)

Target: NANOGP11
Molecular classification: Pseudogene, Homeobox gene family

Overview

Nanog homeobox pseudogene 11 (NANOGP11) is part of a family of NANOG pseudogenes generated during human evolution, with NANOGP11 being a processed, intronless, non-protein-coding locus. While the original NANOG protein is a master transcription factor for pluripotency and self-renewal in embryonic stem cells[2][3][5], NANOGP11 itself does not encode a functional product or participate in stem cell regulation, reprogramming, or disease processes[8][3]. Its presence in the genome reflects molecular evolutionary history rather than a role in cellular physiology or therapeutic potential.

Other names: Nanog pseudogene 11NanogP11

Beyond the preview

Go deeper on Nanog homeobox pseudogene 11 (NANOGP11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanog homeobox pseudogene 11 (NANOGP11).

Explore the full profile